- Corneal Pachymeters
- Optical Coherence Tomography (OCT) Imaging Systems
- Retinal Tomography and Angiography Systems
- Spectral Domain Optical Coherence Tomography (OCT) Systems
- Visual Field Testing Equipment
The global asia pacific glaucoma diagnostic devices market size valued USD 576.0Â million in 2020 and expected to reach USD 999.84 million by 2027, at a CAGR of 18.5% during the forecast period 2021-2027. Glaucoma is a disease characterized by increase in the intraocular pressure in eye leads to optic nerve damage and causes loss of vision or blindness. Most common types of glaucoma include closed-angle glaucoma and open angle glaucoma. Glaucoma can be diagnosed by determining the status of optic nerve, intraocular pressure, and drainage angle. Increase in the geriatric population in China, India, and Japan, rise in prevalence of glaucoma, adoption of newer devices for glaucoma diagnosis, increase in healthcare expenditure, and advances in healthcare infrastructure are expected to boost the Asia Pacific glaucoma diagnostic devices market. However, high cost of devices and stringent regulatory guidelines for product approval may restrain the growth of Asia Pacific glaucoma diagnostic devices market.
Fastest Growing Market
Drivers: Increasing number of geriatrics, increasing awareness, growing healthcare expenditure and screening. Restraints: The high cost of eye surgeries, excellent efficiency of the present drugs
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.